Venture Capital

With new trials in myositis and pediatrics, Cartesian Therapeutics pioneers an outpatient cell therapy, moving beyond cancer to treat chronic autoimmune diseases.

With record revenue and a bold AI strategy, Opera heads to a key investor conference. Can its 'agentic' browsers redefine the web and win market share?

Biocytogen and Acepodia are expanding their partnership to create next-gen ADCs with two targets and two warheads, aiming to defeat drug-resistant cancers.

With new funding and a veteran biotech leader, Montreal's Find Therapeutics advances its first-in-class therapy aimed at reversing nerve damage in MS.

The biotech firm now expects Phase 2 results in Q3 2026, accelerating hope for new CNS treatments and signaling strong operational momentum to investors.

Thousands of parents will explore a burgeoning marketplace of school options in Las Vegas, from public charters to private academies, amid new state policies.

Ocugen heads to a top investor conference with a bold plan for its gene-agnostic therapy, aiming to treat blindness and secure its future in a crowded market.

ChipMOS reports stunning 20.8% Q4 growth, highlighting a memory chip frenzy fueled by AI and datacenters. Is this the start of a new tech supercycle?

Backed by CRISPR pioneers and $16M, a new biotech aims to make personalized gene therapies a scalable reality for millions with rare genetic disorders.

With support from a bipartisan alliance, nonprofit newsroom Votebeat is scaling up its expert reporting to fight election misinformation and bolster trust.

A massive 20-year pact between Meta and Vistra will revive three nuclear plants, adding new carbon-free power to fuel the AI and data center revolution.

At CES 2026, Chinese startup KunlunMeta and AMD launched a portable AI terminal, promising unprecedented mobile productivity and data privacy.

Amid a major corporate restructure, Atos partners with the World DanceSport Federation, betting on tech to transform the ballroom and secure its market lead.

A 2.9 MEUR deal for GomSpace to design lunar spacecraft for a major North American firm signals a new era for small satellites in deep space exploration.

Belgian biotech MRM Health gets the green light for a Phase 2b trial of MH002, a novel 'living drug' aimed at revolutionizing ulcerative colitis care.

The global VR leader continues its rapid Canadian growth, opening a high-tech virtual reality venue in Vaughan amid a booming market for immersive group fun.

With its radical solar car on the line, Aptera appoints a VW and BMW veteran as Chairman. Can traditional auto expertise finally launch a new era of efficiency?

With a new CEO from Illumina and Exact Sciences, Quanterix signals a strategic shift from tech development to aggressive market and clinical expansion.

From firefighting robots to AI health diagnostics, Hong Kong's record delegation at CES 2026 wins big, signaling its arrival as a global tech powerhouse.

With a massive IKEA partnership, supply chain leader Made4net proves unified omnichannel fulfillment is no longer an option, but the new standard for retail.